CAR-T cell therapiesTocilizumabCRSuniversity hospitalmultiorgan failure
…ty hospital is involved as a sponsor of clinical trials on both CAR-T cell therapies and bispecific antibodies (BsAbs), actively contributing to the…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 541–600 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Locoregional therapy3Pancreatic Enzyme Replacement Therapy3Peroral endoscopic myotomy3Pharmacologic treatment3Positive Airway Pressure (PAP) therapy3Regional analgesia3Traditional Chinese Medicine3Vitamin supplementation3advanced therapies3anti-PD1 therapy3anti-VEGF therapy3anti-programmed cell death protein-1 therapy3antiarrhythmic therapy3anticancer therapies3anticancer therapy3autologous stem cell transplantation3behavioural therapy3cancer therapies3chimeric antigen receptor T-cell therapy3clinical management3cognitive–behavioural therapy3conventional immunosuppression3coronary revascularisation3deworming3diabetes treatment3dopaminergic therapy3haematopoietic stem cell transplantation3immunotherapy treatment3inhaled corticosteroids3intensive care treatment3intravenous fluid therapy3intravenous iron therapy3lethal palliation3lifestyle changes3local anaesthesia3neurocritical care3novel therapies3nutritional support3occupational therapy3oral antibiotics3outpatient treatment3palliative chemotherapy3pharmacological interventions3physical rehabilitation3preventive measures3standard therapy3standard treatment3stent retriever thrombectomy3supportive treatment3surgical interventions3surgical management3symptomatic therapy3targeted treatment3topical therapy3tracheostomy3tyrosine kinase inhibitors3ultrasound-guided nerve blocks3vasodilator therapy3vasopressors3ventriculoperitoneal shunting3
Articles mentioning treatments
7,227 articles · page 390 of 603CAR-T cell therapyTocilizumabhaematologic malignanciesuniversity hospitalCRScorticosteroidscytokine release syndromemultiorgan failure
…strate the central role we play in this therapeutic innovation. CAR-T cell therapy is a major breakthrough in the management of haematologic malig…
ketogenic dietAicardi syndromevigabatrinperampanellevetiracetamhydrocortisonelamotriginefenfluraminevalproic acidtopiramate+2 more
…motrigine, valproic acid, vigabatrin, levetiracetam, primidone, ketogenic diet, rufinamide, topiramate, zonisamide, perampanel, and hydrocorti…
therapeutic anticoagulationaspirinVTEhaemorrhagecerebral accidents
…drug chart and administered at the correct time. With regard to therapeutic anticoagulation, statistical significance was found in the documentation of ind…
Oncology treatmentenzalutamideapalutamidepazopanibabirateroneolaparibsunitinibcapecitabineimatinibosimertinib+8 more
…Background and Importance Oncology treatment requires continuous monitoring and appropriate pharmacotherapeu…
Chimeric Antigen Receptor T-cell (CAR-T) therapyaxicabtagene ciloleuceltisagenlecleucelciltacabtagene autoleucelmultiple myelomaDLBCLanakinraacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANS+1 more
…Background and Importance Chimeric Antigen Receptor T-cell (CAR-T) therapy has improved outcomes in relapsed or refractory haematological …
Combination therapylinezolidceftazidime-avibactamcolistinoxazolidinonesnosocomial infectionsurinary tract infectionsmultidrug-resistant infections
…inly for respiratory (21.9%) and urinary tract infections (8%). Combination therapy was used in 26.7% of prescriptions, mainly for synergistic purp…
Immune checkpoint inhibitorspembrolizumabtertiary hospitalNSCLCmetastatic non-small-cell lung adenocarcinomaproton pump inhibitors
…Background and Importance Immune checkpoint inhibitors (ICI) have become a standard treatment in multiple malignancies…
DAPTaspiriniP2Y12chronic kidney diseaseacute myocardial infarctionatrial fibrillationdiabetes mellitustertiary hospitalNon-ST-segment Elevation Myocardial InfarctionST-segment elevation myocardial infarction+5 more
…in discharge treatment between men and women were observed (eg, DAPT and anticoagulation), these were not statistically significant.…
Therapeutic drug monitoringlinezolidamiodaroneclarithromycinamlodipinesevere infectionslevothyroxineRifampicinphenobarbital
…acokinetic variability may compromise both efficacy and safety. Therapeutic drug monitoring (TDM) can optimise dosing and reduce the risk of adverse effect…
CAR T-cell therapyECOG Performance StatusTisagenlecleucelKymriahhematologic malignanciesTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelmantle cell lymphoma+5 more
…pitalisation was 23.5 days (IQR 17-28).Conclusion and Relevance CAR T-cell therapy in real-world-practice achieves high early response rates, alth…
corticosteroid therapyipilimumablevofloxacinnivolumabprednisoneipilimumab/nivolumabamoxicillin–clavulanatelevetiracetamadvanced clear-cell renal carcinoma
…diated origin of hepatic and neurological alterations optimised corticosteroid therapy and improved patient safety.Material and Methods Ipilimumab/niv…